Year: 2026
Type: article
Abstract: Malignant pleural mesothelioma (MPM) is a rare and aggressive malignancy primarily caused by asbestos exposure. Over the past decade, treatment strategies have evolved significantly, incorporating advancements in systemic therapies, immunotherapy, and personalized medicine. Multimodality treatment — integrating surgery, systemic therapy, and radiotherapy — may improve outcomes in carefully selected patients. This manuscript provides an overview of current treatment modalities for pleural mesothelioma (PM), emphasizing recent developments and emerging therapies.
Source: Nowotwory Journal of Oncology
DOI: 10.5603/njo.108985
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7160564293
FWCI:
Cites:
Cited by:
Related to:
